RESEARCH TRIANGLE PARK, NC - May 17, 1996 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced that it has established a subsidiary in South Africa and opened new offices in Vienna and Helsinki to help meet the need for drug development services in those areas. Quintiles, a leading contract research organization (CRO), provides drug development services on a global basis for the pharmaceutical and biotechnology industries.

Quintiles South Africa, located near Pretoria, establishes a presence for Quintiles on the African continent and strengthens Quintiles' services in the Southern hemisphere. The office also is intended to serve as a springboard to the rest of Africa and the Middle East. Quintiles South Africa is headed by Dr. Fourie de Kock, who is director of clinical operations for the unit and previously served as a medical manager for Hoffmann-La Roche. The site expands the pool of appropriate study patients for both international and local clinical trials. The office currently has numerous projects underway at about 50 medical sites.

Quintiles Vienna allows the company to expand its services in emerging markets in Central and Eastern Europe. The Vienna office enables the company to provide clinical development services in Austria, the Czech Republic, Hungary, Poland, Russia, Slovakia and Slovenia. The office is managed by Heinz Carmann, M.D., who joined Quintiles from Roche Vienna and also serves as director of clinical operations for Central and Eastern Europe. Quintiles Vienna staff has extensive experience in medical research and strong relationships with clinical investigators and regulatory agencies.

Quintiles' new Helsinki office strengthens the company's ability to provide clinical research services in Scandinavia. The office is located in an industrial park for high tech companies and is managed by PSivi Itkonen, who was previously a field based clinical trial co-ordinator based in Finland through Quintiles Ltd. The Helsinki office is part of Quintiles' service expansion in Scandinavia which also includes a new field staff in Norway.

"Our new offices in South Africa, Vienna and Helsinki fit our global strategy of growth through organic expansion," said Dennis Gillings, Chairman and CEO of Quintiles Transnational Corp. "Each of these offices has experienced local management and staff and follows the worldwide Quintiles standard operating procedures for quality global drug development. They are fully integrated with our existing range of services."

Headquartered near Research Triangle Park, North Carolina, Quintiles has 38 operating units in 19 countries. The company's professional services include clinical trials and data management, biostatistical analysis, formulation and packaging for clinical trials, centralized clinical trial laboratory services, preclinical and Phase I testing, and strategic, regulatory and health economics consulting.

The addresses for Quintiles' new offices are:

Quintiles South Africa P.O. Box 10684 Hennopsmeer 0064 South Africa Tel: (27) 12 663-3178 Fax:(27) 12 663-3179

Quintiles GesmbH Handelskai 388, Top 431 A-1020 Vienna Austria Tel: (43)-1-726-30-10-0 Fax: (43)-1-726-30-10-100

Quintiles Scandinavia, Helsinki Tapiola Spektri Pilotti Building 3F ValkjSrventie 2 SF-02130 Espoo Finland Tel: (35)-8-061-333-000 Fax: (35)-8-061-333-009